The genus Psilocybe has been characterized by central nervous system (CNS) effects and as a source of therapeutic drugs such as the alkaloids psilocybin and psilocin—secondary metabolites that produce rapid anxiolytic and antidepressant effects in preclinical and clinical studies. Furthermore, these mushrooms also contain bioactive primary metabolites, for example, the interesting case of...
The genus Psilocybe currently comprises approximately 165 species that are hallucinogenic. Chemical studies on them have revealed the presence of alkaloids with indole and β-carboline structures, which are responsible for their psychotropic properties. However, scarce information has been reported on other classes of metabolites present in Psilocybe mushrooms. The objective of this review was...
The pharmacological treatment of depression consists of taking antidepressant drugs for prolonged periods; its modest therapeutic effect can often be associated with significant adverse effects, while its discontinuation can lead to relapses. Psilocybin is today a novel and breakthrough therapy for major depression. It is a natural alkaloid in Psilocybe mushrooms, which are endemic to Mexico....